Abstract
Helicobacter infection has been associated with hepatobiliary diseases in humans and animals. The aims of this study were to identify Helicobacter species in the hepatobiliary tract of dogs and to elucidate the possible association of these bacteria in liver diseases. Twenty-seven gastric and hepatobiliary samples were collected from 33 dogs with hepatic lesions and 17 dogs with no liver histological changes. Warthin-Starry staining, immunohistochemical assay, and PCR were performed to detect the presence of Helicobacter. Helicobacter genus was detected in 21.2% of the samples with hepatic lesions. The main lesion was chronic hepatitis. Immunohistochemistry revealed infection in liver (1/5) and gallbladder (1/3) 32 samples. The sequence analysis of seven amplicons of the 16S rRNA gene of Helicobacter genus from hepatobiliary samples showed 97.8 to 100% of nucleotide identity with gastric helicobacter. One amplicon of the ureA and ureB gene of Helicobacter genus from the stomach showed 89.1 to 90.7% nucleotide identity with H. heilmannii. The presence of Helicobacter genus in liver samples showing hepatic lesions suggests the involvement of these bacteria in the etiology of hepatobiliary disease in dogs. DNA sequences were similar to gastric Helicobacter species, reinforcing the hypothesis of bacterial translocation from the stomach to liver by the biliary pathway.
Keywords: Canine, Helicobacter, Hepatobiliary diseases, Molecular biology
Introduction
Since the discovery of Helicobacter pylori as a cause of gastritis and gastric neoplasia in human beings [1], more than 40 additional Helicobacter species have been isolated from the stomach, intestinal tract, and liver of various mammalian and avian species. Gastric non-H. pylori Helicobacter species were originally referred to as Gastrospirillum hominis and later as H. heilmannii. H. heilmannii was subdivided in two taxa (type 1 and type 2). H. suis has been accepted as a new gastric Helicobacter corresponding to H. heilmannii type 1 while the H. heilmannii type 2 is formed by a group of species that colonize the gastric mucosa: H. felis, H. bizzozeronii, H. salomonis, H. cynogastricus, H. baculiformis, and Candidatus H. heilmannii [2]. In addition, the name Helicobacter heilmanni sensu lato was proposed when histological or crude taxonomical data were obtained, whereas Helicobacter heilmannii sensu stricto should be used when definite identification is attained [3]. The Helicobacter species that colonize the intestine and hepatobiliary system are known as enterohepatic species [4].
Some inflammatory and neoplastic diseases of the hepatobiliary system have been associated with Helicobacter infection in humans, creating new interest in the role of Helicobacter spp. in hepatobiliary diseases [5, 6]. The association between Helicobacter infection and hepatic diseases has also been described in some animal species, involving both gastric and enterohepatic Helicobacter species. In murine species, H. hepaticus induces inflammatory disease and primary neoplasia in the liver, contributing to cholesterol gallstone formation [7, 8]. Chronic hepatitis was associated with H. bilis and H. nemestrinae infection in hamsters [9] (Fox et al., 2009) and in a dog [10] Portal fibrosis and biliary hyperplasia were also observed in infected hamsters [9]. Moreover, in ferrets (Mustela putorius furo), the presence of Helicobacter spp. was associated with cholangiocellular carcinoma and cholangiohepatitis [11].
In pets, there are few reports concerning hepatobiliary diseases and Helicobacter infection. H. canis was isolated from the liver of a puppy with multifocal necrotizing hepatitis [12]. Recently, the presence of Helicobacter spp. in the livers of dogs showing hepatic histological changes was associated with increased hepatocyte proliferation [13]. In cats, Helicobacter was associated with cholangiohepatitis [14]. On the other hand, Helicobacter spp. was identified in the liver and pancreas of healthy cats [15]. Translocation and ascending way are the proposed mechanisms for Helicobacter spp. penetration into the hepatobiliary system [16]. In mice orally infected with H. hepaticus, the bacterium was found first in the intestine and later in the bile duct and liver, demonstrating the capacity for bacterial migration [17]. Tissue invasion may be a prerequisite for or a consequence of Helicobacter-associated disease in the gastrointestinal tract, either as a primary event or secondary to other disease conditions [18].
Dogs are frequently affected by hepatobiliary disorders; however, data regarding the relationship with Helicobacter spp. infection in pets are limited. The aim of this study was to identify specific species of Helicobacter in the hepatobiliary tract of dogs diagnosed with histological liver lesions and to carry out the molecular characterization of these species to elucidate the etiology of these bacteria in liver diseases.
Materials and methods
Animals and sampling procedures
Samples of the gastric mucosa (corpus, fundus, and antrum regions), liver, and gallbladder were collected from 50 dogs submitted to routine necropsy examination. The cause of death was diverse, including disseminated neoplasia, trauma, and cardiac disease. The procedures were performed up until 1 h after death, to avoid autolytic changes in sampled tissues. Fragments were fixed in 10% buffered formalin solution, embedded in paraffin, sectioned at 4 μm and stained with hematoxylin and eosin (HE) and Warthin-Starry (WS) methods.
The criteria for inclusion in this study comprised one or more of the following hepatic histological changes: inflammatory infiltrate, portal fibrosis, vacuolar degeneration of hepatocytes, biliary ductular proliferation, and hepatocellular necrosis. Hematoxylin and eosin staining was performed in liver samples for histological evaluation according to the WSAVA Liver Standardization Group [19]. (2006). In accordance with these criteria, from the initial 50 dogs, 33 animals (17 males and 16 females) were included in this study. Additionally, for comparison 17 dogs showing no liver histological changes were included (control group). WS staining was performed to evaluate the presence of organisms suggestive of Helicobacter spp. Various breeds were involved, and the ages of the dogs (3 months to 19 years) varied.
For PCR assay, one additional sample from each tissue, and also from bile, was placed into a DNase and RNase free microtube and immediately frozen at − 20 °C until DNA extraction. Furthermore, to avoid cross contamination, sample collection were performed using individual sterilized scalpel blades. The study was approved by the institutional ethical committee for animal experimentation (number 35786). None of the animals were euthanized for inclusion in this study.
Molecular characterization
Bacterial DNA was extracted from gastric mucosa, liver, gallbladder mucosa and bile samples as described elsewhere [20]. Bile samples (100 μL) were diluted (1:5) with sterile distillated water before DNA extraction. PCR reactions were performed in a 25 μL final volume using 5 μL of DNA extracted, 0.5 μL (20 pmol) of each primer, 0.4 mM of each dNTP, 1 X PCR buffer (20 mM Tris-HCl pH 8.4 and 50 mM KCl), 1.25 units of Platinum® Taq DNA polymerase (Invitrogen™ Life Technologies, São Paulo, Brazil), and 3 mM of MgCl2. Specific primers pairs were used in PCR assays designed to amplify amplicons of specific genes. These included the 16S rRNA gene and the ureA and ureB genes of the Helicobacter genus (Table 1). Amplification was performed in a thermocycler under time and temperature conditions determined for each primer pair. The amplified products were analyzed by electrophoresis on a 2% agarose gel in TBE buffer, pH 8.4 (89 mM Tris; 89 mM boric acid; 2 mM EDTA), stained with ethidium bromide (0.5 μg/mL) and visualized under UV light. In all amplification reactions for 16S rRNA or ureA and ureB genes, samples of Helicobacter (H. heilmannii, H. felis H. bizzozeronii, H. baculiformis, H. salomonis, and H. cynogastricus) were used as positive controls. The negative control consisted of ultrapure-free water (Invitrogen Corporation, Carlsbad, CA, USA).
Table 1.
Sequences of the primers used in PCR assay to detect Helicobacter spp.
| Primer | Gene amplified |
Sequence 5′ – 3′ | Product size (bp) | Reference |
|---|---|---|---|---|
|
H276F H676R |
16S rRNA |
CTATGACGGGTATCCGGC ATTCCACCTACCTCTCCCA |
399 | 35 |
|
U430F U1735R |
Urease gene |
GCKGAWTTGATGCAAGAAGG CTTCGTGRATTTTAARRCCAAT |
1224 | 27 |
Sequencing and phylogenetic analysis
The PCR amplicons were purified using the illustra GFX PCR DNA and Gel Band Purification Kit (GE Healthcare, Little Chalfont, Buckinghamshire, UK), quantified in a Qubit Fluorometer using Quant-iT dsDNA BR Assay Kit (Invitrogen Life Technologies, Eugene, Oregon, USA), and sequenced in an ABI3500 Genetic Analyzer sequencer with the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, California, USA) using the forward and reverse primers. Sequence quality analyses and contig assembly were performed using Phred and CAP3 software (http://asparagin.cenargen.embrapa.br/phph/) respectively, and the sequences were accepted if base quality was ≥ 20. Sequence similarity searches were performed with sequences deposited in GenBank using the basic local alignment search tool (BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Phylogenetic tree based on nucleotide sequences was obtained using the neighbor-joining method with the Kimura two-parameter model using MEGA software package (version 5.05) [21]. Bootstrapping was statistically supported with 1000 replicates. Sequence identity matrix was performed using the BioEdit software version 7.1.3.0.
Immunohistochemical assay
Immunohistochemistry (IHC) was performed using polyclonal rabbit anti-Helicobacter pylori antibody (Dako, Denmark) on PCR-positive hepatobiliary samples. Histological sections were deparaffinized and subjected to antigen retrieval (citrate buffer, pH 6.0) on microwave. Endogenous peroxidase was blocked using hydrogen peroxide. Sections were incubated with primary antibody (1:100) overnight at 4 °C. The samples were incubated with the secondary antibody (HRP polymer, Zymed, CA). Finally, the antigen-antibody complex was visualized by its reaction with 3,3′-diaminobenzidine substrate-chromogen solution (Zymed, California, CA). Slides were counterstained with hematoxylin and coverslipped. Positive (tissue fragment from gastric mucosa infected with Helicobacter spp.) and negative (mouse serum substituted for the primary antibody) controls were used in all reactions according to the manufacturer’s recommendations.
Results
Histopathological hepatic findings
Of the 50 animals, 33 presented liver histological lesions established as a criteria inclusion in this study. Seventeen animals with no histological changes were included as a control group. The main histological finding was mild to moderate inflammatory infiltrate involving the portal tracts and lobular parenchyma. Chronic hepatitis (24/33) was predominantly composed of lymphocytes and plasma cells with a few neutrophils and macrophages associated with hepatocellular necrosis and fibrosis; in contrast, in acute hepatitis (4/33), there was neutrophilic inflammation and hepatocellular necrosis. A minimal to moderate quantity of fibrous connective tissue occurred in portal fibrosis (4/33) (Fig. 1a), with or without inflammatory cells. In some cases, the hepatocytes appeared with a swelling and pale staining cytoplasm or a vacuolar change of the cytoplasm, characterizing vacuolar degeneration (6/33) (Fig. 1b). Chronic cholangitis occurred in one dog. Microscopically, it was characterized by consistent lymphocyte and plasma cell infiltrate in portal areas, associated with portal fibrosis and biliary ductular proliferation (5/33). Hepatocellular necrosis (6/33) showed a focal or multifocal distribution in the parenchyma (Fig. 1c).
Fig. 1.
a Portal fibrosis and biliary ductular proliferation in a chronic hepatitis case. HE. Bar, 100 μm. b Diffuse vacuolar degeneration in a chronic hepatitis case. HE. Bar, 100 μm. c Chronic cholangitis with biliary ductular proliferation and hepatocellular necrosis (arrow) in a chronic hepatitis case. HE. Bar, 100 μm. dHelicobacter spp. colonization in the fovea of gastric mucosa. WS staining. Bar, 20 μm. e Positive immunostaining to anti-H. pylori in liver (arrow). IHC for anti-H. pylori. Bar, 10 μm. f Positive immunostaining to anti-H. pylori in gallbladder (arrow). IHC for anti-H. pylori. Bar, 10 μm
Warthin-Starry staining and immunohistochemical assay
In 29 (87.9%) dogs long spiral-shaped bacteria were detected in superficial mucus, fovea (Fig. 1d), and gastric pits. The bacteria were found in large clusters and also occurred isolated. None of the liver and gallbladder samples were positive by this method. A positive immunostaining was observed (Fig. 1e, f) in two samples (one from the liver and one from the gallbladder).
PCR assay
In the gastric mucosa, a 399 -bp amplicon that corresponds to the 16S rRNA gene of Helicobacter genus was detected in 90.9% of the samples (30/33). In one dog, a negative sample by WS staining was positive by PCR for Helicobacter spp.
In the hepatobiliary system, a 399-bp amplicon consistent with the Helicobacter genus was obtained in 15.2% (5/33) of the liver samples presenting histological changes. One dog presented a positive Helicobacter genus reaction for both the liver and gallbladder. None of the bile samples were positive for the Helicobacter genus. The positive samples for 16S rRNA Helicobacter genus were tested for the ureA and ureB gene. Only one dog was positive for 16S rRNA Helicobacter genus and negative for the ureA and ureB gene. Table 2 illustrates the positive results of the hepatobiliary system samples by PCR assay and their respective results for gastric mucosa. Hepatobiliary samples from animals with no histological changes were negative in PCR assays.
Table 2.
PCR results for 16S rRNA and ureA and ureB genes and histological liver changes from dogs with Helicobacter spp. positive samples from the alimentary system
| Animal | PCR assay | Hepatic histological changes | |||||
|---|---|---|---|---|---|---|---|
| Liver | Gallbladder mucosa | Gastric mucosa | |||||
| 16S rRNA | Urease A/B | 16S rRNA | Urease A/B | 16S rRNA | Urease A/B | ||
| Dog 4 | KC007543* | + | – | n/a | + | + | Chronic hepatitis |
| Dog 6 | KC007544* | + | KC007547* | – | + | + | Chronic hepatitis |
| Dog 8 | – | n/a | KC007545* | + | + | + | Chronic hepatitis |
| Dog 13 | KC007541* | + | – | n/a | + | + | Vacuolar degeneration |
| Dog 21 | KC007546* | + | – | n/a | + | KT288228* | Chronic hepatitis |
| Dog 32 | – | n/a | KC007542* | + | + | + | Chronic hepatitis, vacuolar degeneration |
| Dog 33 | + | + | – | n/a | + | + | Chronic hepatitis, biliary ductular proliferation, fibrosis |
Phylogenetic analysis
The seven nucleotide sequences of the 16S rRNA Helicobacter genus from the liver and gallbladder samples displayed high nucleotide identity (97.8 to 100%) with H. felis, H. bizzozeronii, H. cynogastricus, H. salomonis, H. baculiformis, and H. heilmannii (H. heilmannii sensu lato) and clustered in the phylogenetic tree with these strains (Fig. 2). The positive sample from the stomach by the ureA and ureB gene (dog 21) showed high nucleotide identity (89.1 to 90.7%) with strains that belong to H. heilmannii (H. heilmannii sensu lato and sensu stricto) and clustered with them in the phylogenetic tree (Fig. 3). The 16S rRNA gene nucleotide sequences of the liver from dog 33 and all the samples of liver and gallbladder ureA and ureB gene tested were not included in the phylogenetic analysis due to the low quality of the sequences.
Fig. 2.
Neighbor-joining phylogenetic tree based on partial sequences with 331 bp (nt 459–789) of the 16S rRNA gene of Helicobacter spp. from the liver and gallbladder samples of dogs. The numbers adjacent to the nodes represent the percentage of bootstrap support (1000 replicates) for the clusters. Bootstrap values less than 50% are not shown. ♦ Sequences from this study
Fig. 3.
Neighbor-joining phylogenetic tree based on partial sequences with 795 bp (nt 422–1216) ureA and ureB gene of Helicobacter spp. from the stomach sample of dog 21. The numbers adjacent to the nodes represent the percentage of bootstrap support (1000 replicates) for the clusters. Bootstrap values less than 50% are not shown. ♦ Sequences from this study
Discussion
Helicobacter spp. have been reported to infect the gastric mucosa of pets in many countries, with a prevalence ranging from 41 to 100% [22, 23]. However, data about Helicobacter infection in the liver and gallbladder are scarce in pets [12–14]. Helicobacter infection and hepatobiliary diseases [24–26]. In our study, Helicobacter was detected in 21.2% of the hepatobiliary samples (15.2% in the liver and 9.1% in the gallbladder). Moreover, only liver samples with histological changes were positive for Helicobacter genus by PCR.
The main lesion observed in infected animals was chronic hepatitis, associated or not with degenerative or proliferative changes. Similar findings were reported for cats [14], prairie dogs [27], and a ferret [11] in which Helicobacter DNA fragments were detected. An association between H. bilis infection and chronic hepatitis, fibrosis, and biliary hyperplasia was also reported in hamsters [9] In contrast, Helicobacter spp. was identified in liver and pancreas samples from healthy cats [15]. In a study using liver samples from human patients with cholangitis and cirrhosis, an association with the presence of H. pylori and Helicobacter spp. DNA was observed, suggesting the involvement of bacteria in liver diseases [25]. In addition, in a previous study, we have showed in dogs an association between liver infection by Helicobacter spp. and increased hepatocyte proliferation [13].
Identification of Helicobacter spp. in the gastric mucosa using WS staining showed a high association with PCR assay, but for hepatobiliary system, no bacteria were observed in histological slides, even for PCR positive specimens. Similar results were reported in the liver of cats infected with Helicobacter-like organisms that were PCR positive but negative by WS or Steiner staining [14]. In contrast, some authors have demonstrated the presence of Helicobacter spp. in the hepatobiliary system using WS staining [12, 24]. Nevertheless, even with special stains, the bacterial colonization observed is low [28]. Another point to be considered is that as a consequence of the high number of wavy reticular fibers in the liver, identifying spiral shaped bacteria using histochemical methods in this tissue could result in false negatives. Even with the use of immunohistochemical assay the bacteria was detected only in two samples. It seems that the microscopic analysis for observing organisms that suggest Helicobacter spp. in liver sections by WS staining or IHC is much harder than that in gastric mucosa samples. This difference between the IHC, WS staining and PCR results may be explained by a heterogeneous colonization in the liver, as has been demonstrated in gastric mucosa [20].
In our study, the species detected in hepatobiliary samples by 16S rRNA phylogenetic analysis were clustered with gastric helicobacters, such as H. baculiformis, H. cynogastricus, H. salomonis, H. felis, H. bizzozeronii, and H. heilmannii (H. heilmannii sensu lato). Detection of ureA and ureB gene was performed in hepatobiliary samples, and the amplicons generated were sequenced; however, the quality was insufficient to identify the infecting species [29]. The quality of the amplicons generated may be related to mixed infections that, similarly as in gastric mucosa, may occur in hepatobiliary system [30]. Most likely, the origin of infection or the presence of Helicobacter spp. DNA in liver and gallbladder samples was from gastric mucosa. Gastric helicobacters may be present in the stomach without causing any clinical symptoms, but they could be opportunistic pathogens in the biliary tract. Other studies, which have detected H. pylori DNA in bile and liver samples in human beings, have also suggested the enterohepatic transport as the origin for hepatobiliary infection [25, 31].
Bacterial translocation occurs both in humans and animals, and three primary mechanisms have been identified: intestinal bacterial overgrowth, increased permeability of the intestinal mucosal barrier, and deficiencies in host immune defenses [32]. In the case of Helicobacter spp., there are two proposed pathways for liver colonization: translocation from the stomach to the liver through the duodenum and biliary tract or through the hepatic portal vein. Data indicate the biliary pathway as the most plausible route [33]. In this study, the isolate sequenced from gastric mucosa (ureA and ureB gene, dog 21) displayed high nucleotide identity with H. heilmannii (H. heilmannii sensu lato and sensu stricto). The liver sample from the same animal (16S rRNA gene, dog 21) also shared high nucleotide identity with H. heilmannii (H. heilmannii sensu lato), but also with other gastric Helicobacter. These results reinforce the hypothesis of bacterial translocation from gastric origin, since both species are reported in samples from gastric mucosa [23, 34].
The detection of Helicobacter spp. in bile samples was reported in humans and rodents with hepatobiliary disorders [7, 31, 35]. These data indicate a possible role for Helicobacter infection in the development of hepatobiliary diseases in humans and animals, nevertheless more studies in pets are necessary. In our study, no bile samples were positive by PCR. Data indicate that when a nested PCR was used, a higher occurrence of Helicobacter spp. infection was observed in bile samples [26, 35]. Another point that can explain the negative results in bile samples is the low DNA quantities [26] and the presence of inhibiting substances [36]. Additionally, considering the physiology of the gallbladder, the biliary flow could inhibit some bacterial colonization.
Conclusion
In the present study, Helicobacter was detected in dogs showing hepatic histological changes. In the literature, hepatobiliary diseases were associated with infection by different species of Helicobacter in humans and animals. These results suggest a possible role for Helicobacter spp. in the etiology of hepatobiliary disease in dogs. In addition, the DNA sequences were most similar to gastric Helicobacter species, reinforcing the hypothesis of bacterial translocation from the stomach to the liver by the biliary pathway. More studies have to be performed to elucidate the pathogenicity of Helicobacter spp. infection in the hepatobiliary tract of dogs.
Acknowledgments
The authors wish to thank Dr. Annemieke Smet, Ghent University, Belgium, for positive controls of H. baculiformis, H. salomonis, and H. cynogastricus.
Funding information
This study was financially supported by CNPq and Fundação Araucária, Brazil.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Ito T, Kobayashi D, Uchida K, Takemura T, Nagaoka S, Kobayahi I, et al. Helicobacter pylori invades the gastric mucosa and translocates to the gastric lymph nodes. Lab Investig. 2008;88:664–681. doi: 10.1038/labinvest.2008.33. [DOI] [PubMed] [Google Scholar]
- 2.Bento-Miranda M, Figueiredo C. Helicobacter heilmannii sensu lato: an overview of the infection in humans. World J Gastroenterol. 2014;20:17779–17787. doi: 10.3748/wjg.v20.i47.17779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Haesebrouck F, Pasmans F, Flahou B, Smet A, Vandamme P, Ducatelle R. Non-Helicobacter pylori Helicobacter species in the human gastric mucosa: a proposal to introduce the terms H. heilmannii sensu lato and sensu stricto. Helicobacter. 2011;16:339–340. doi: 10.1111/j.1523-5378.2011.00849.x. [DOI] [PubMed] [Google Scholar]
- 4.Owen RJ. Helicobacter-species classification and identification. Br Med Bull. 1998;54:17–30. doi: 10.1093/oxfordjournals.bmb.a011667. [DOI] [PubMed] [Google Scholar]
- 5.Karagin PH, Stenram U, Wadstrom T, Ljungh A. Helicobacter species and common gut bacterial DNA in gallbladder with cholecystitis. World J Gastroenterol. 2010;16:4817–4822. doi: 10.3748/wjg.v16.i38.4817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Xuan SY, Li N, Qiang X, Zhou RR, Shi YX. Helicobacter infection in hepatocellular carcinoma tissue. World J Gastroenterol. 2006;12:2335–2340. doi: 10.3748/wjg.v12.i15.2335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, et al. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology. 2005;128:1023–1033. doi: 10.1053/j.gastro.2005.01.008. [DOI] [PubMed] [Google Scholar]
- 8.Rogers AB, Boutin SR, Whary MT, Sundina N, Ge Z. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol. 2004;32:668–677. doi: 10.1080/01926230490524247. [DOI] [PubMed] [Google Scholar]
- 9.Fox JG, Shen Z, Muthupalani S, Rogers AR, Kirchain SM, Dewhirst FE. Chronic hepatitis, hepatic dysplasia, fibrosis, and biliary hyperplasia in hamsters naturally infected with a novel Helicobacter classified in the H. bilis cluster. J Clin Microbiol. 2009;47:3673–3681. doi: 10.1128/JCM.00879-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Boomkens SY, Slump E, Egberink HF, Rothuizen J, Penning LC. PCR screening for candidate etiological agents of canine hepatitis. Vet Microbiol. 2005;108:49–55. doi: 10.1016/j.vetmic.2005.03.003. [DOI] [PubMed] [Google Scholar]
- 11.Garcia A, Erdman SE, Xu S, Feng Y, Rogers AB, Schrenzel MD, et al. Hepatobiliary inflammation, neoplasia, and argyrophilic bacteria in a ferret colony. Vet Pathol. 2002;39:173–179. doi: 10.1354/vp.39-2-173. [DOI] [PubMed] [Google Scholar]
- 12.Fox JG, Drolet R, Higgins R, Messier S, Yan L, Coleman BE, et al. Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol. 1996;34:2479–2482. doi: 10.1128/jcm.34.10.2479-2482.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Marcasso RA, Takemura LS, Camargo PL, Alfieri AA, Bracarense APFRL. Presence of Helicobacter DNA in hepatic tissues in dogs with nonspecific hepatic lesions. Afr J Microbiol Res. 2016;10:93–99. doi: 10.5897/AJMR2015.7563. [DOI] [Google Scholar]
- 14.Greiter-Wilke A, Scanziani E, Soldati S, McDonough SP, McDonough PL, Center SA, et al. Association of Helicobacter with cholangiohepatitis in cats. J Vet Int Med. 2006;20:822–827. doi: 10.1111/j.1939-1676.2006.tb01792.x. [DOI] [PubMed] [Google Scholar]
- 15.Sjodin S, Trowald-Wigh G, Fredriksson M. Identification of Helicobacter DNA in feline pancreas, liver, stomach, and duodenum: comparison between findings in fresh and formalin-fixed paraffin-embedded tissue samples. Res Vet Sci. 2011;91:e28–e30. doi: 10.1016/j.rvsc.2011.02.001. [DOI] [PubMed] [Google Scholar]
- 16.Kandelaki S, Kordzaia D. Helicobacter and hepatobiliary diseases: conceptual view and review of the literature. Georgian Med News. 2014;232-233:92–98. [PubMed] [Google Scholar]
- 17.Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun. 1996;64:3673–3681. doi: 10.1128/iai.64.9.3673-3681.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Schauer DB. Enterohepatic Helicobacter Species. In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: physiology and genetics. Washington, DC: ASM Press; 2001. [Google Scholar]
- 19.World Small Animal Veterinary Association (2006) WSAVA standards for clinical and histological diagnosis of canine and feline liver disease. Liver Standardization Group, Jan Rothuizen. Saunders Elsevier Press
- 20.Takemura LS, Camargo PL, Alfieri AA, Bracarense AP. Helicobacter spp. in cats: association between infecting species and epithelial proliferation within the gastric lamina propria. J Comp Pathol. 2009;141:127–134. doi: 10.1016/j.jcpa.2009.01.002. [DOI] [PubMed] [Google Scholar]
- 21.Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:e2725–e2729. doi: 10.1093/molbev/mst197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Strauss-Ayali D, Scanziani E, Deng D, Simpson KW. Helicobacter spp. infection in cats: evaluation of the humoral immune response and prevalence of gastric Helicobacter spp. Vet Microbiol. 2001;79:253–265. doi: 10.1016/S0378-1135(00)00360-6. [DOI] [PubMed] [Google Scholar]
- 23.Van den Bulck K, Decostere A, Baele M, Driessen A, Debongnie JC, Burette A, et al. Identification of non-Helicobacter pylori spiral organisms in gastric samples from humans, dogs, and cats. J Clin Microbiol. 2005;43:2256–2260. doi: 10.1128/JCM.43.5.2256-2260.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Nam C, Ohmachi Y, Kokubo T, Nishikawa T, Uchida K, Nakayama H. Histopathological studies on cases of chronic mouse hepatitis by natural Helicobacter infections. J Vet Med Sci. 2013;75:1231–1235. doi: 10.1292/jvms.12-0304. [DOI] [PubMed] [Google Scholar]
- 25.Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol. 2000;38:1072–1076. doi: 10.1128/jcm.38.3.1072-1076.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Pellicano R, Mazzaferro V, Grigioni WF, Cutufia MA, Fagoonee S, Silengo L, et al. Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol. 2004;10:598–601. doi: 10.3748/wjg.v10.i4.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Beisele M, Shen Z, Parry N, Mobley M, Taylor NS, Bucley E, et al. Helicobacter marmotae and novel Helicobacter and Campylobacter species isolated from the livers and intestines of prairie dogs. J Med Microbiol. 2011;60:1366–1374. doi: 10.1099/jmm.0.032144-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage P, Balabaud C, et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer. 2000;89:1431–1439. doi: 10.1002/1097-0142(20001001)89:7<1431::AID-CNCR4>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
- 29.O'Rourke JL, Solnick JV, Neilan BA, Seidel K, Hayter R, Hansen LM, et al. Description of 'Candidatus Helicobacter heilmannii' based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol. 2004;54:2203–2211. doi: 10.1099/ijs.0.63117-0. [DOI] [PubMed] [Google Scholar]
- 30.Yamanaka H, Arita M, Oi R, Ohsawa M, Mizushima M, Takagi T, et al. Prevalence of an unidentified Helicobacter species in laboratory mice and its distribution in the hepatobiliary system and gastrointestinal tract. Exp Anim. 2013;62:109–116. doi: 10.1538/expanim.62.109. [DOI] [PubMed] [Google Scholar]
- 31.Tiwari SK, Khan AA, Ibrahim M, Habeeb MA, Habibullah CM. Helicobacter pylori and other Helicobacter species DNA in human bile samples from patients with various hepato-biliary diseases. World J Gastroenterol. 2006;12:2181–2186. doi: 10.3748/wjg.v12.i14.2181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.O'Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, et al. Microbiology of bacterial translocation in humans. Gut. 1998;42:29–35. doi: 10.1136/gut.42.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Pellicano R, Menard A, Rizzetto M, Megraud F. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis. 2008;8:254–260. doi: 10.1016/S1473-3099(08)70066-5. [DOI] [PubMed] [Google Scholar]
- 34.Van den Bulck K, Decostere A, Baele M, Vandamme P, Mast J, Ducatelle R, et al. Helicobacter cynogastricus sp. nov., isolated from the canine gastric mucosa. Int J Syst Evol Microbiol. 2006;56:1559–1564. doi: 10.1099/ijs.0.63860-0. [DOI] [PubMed] [Google Scholar]
- 35.Hamada T, Yokota K, Ayada K, Hirai K, Kamada T, Haruma K, et al. Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease. Helicobacter. 2009;14:545–551. doi: 10.1111/j.1523-5378.2009.00729.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wilson IG. Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol. 1997;63:3741–3751. doi: 10.1128/aem.63.10.3741-3751.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]



